Breaking Visitor Records Year on Year - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Breaking Visitor Records Year on Year


Every year, CPhI Worldwide succeeds in breaking records. This year’s event at the Feria de Madrid is expected to be no different.

Madrid last hosted CPhI Worldwide and its collocated events in 2009, with the organisers expecting a cautious atmosphere due to the unsettled state of the economic climate at the time. However, despite the fact that total number of attendees was down by about 300 compared with the 2008 event in Frankfurt (attributed to the fact that many exhibitors assigned fewer staff to the event), the total number of visitors showed an increase of 5%. Exhibitor numbers also reached a record high of 1808, up by more than a hundred compared with 2008.

The 2010 CPhI Worldwide event, held in Paris, featured a huge 14% increase in attendees compared with 2009. Exhibitor numbers also reached a new record of 1934. Significant growth was also seen in the co-located events, with ICSE being 24% larger than 2009 with 100 new exhibitors and more than 50 new packaging exhibitors, and P-MEC being 25% larger.

Records were one again broken in 2011 in Frankfurt, with 2200 exhibitors and attendees (no number given on the official CPhI website) estimated at smashing all previous records. P-MEC grew by approximately 44% compared with 2010 and ICSE also fared well with more than 220 exhibitors (down compared with previous years due to the introduction of the new InnoPack event).

“The scale of the events has grown exceptionally over the years. As an events organiser, it is important to us that the size does not change the opportunity for each visitor to have a unique and personal experience and we invest a large amount of time and money to ensure this," Greg Kerwin, UBM’s Portfolio Director Pharma, said in a statement. "Despite the financial challenges that still remain globally, to have a year like we just did in Frankfurt means that we are succeeding and that our client base sees the value of these events.”

The Pharmaceutical Technology Europe team attends CPhI every year and the event continues to be a success. This year, we will be based at Stand 10A23. We look forward to meeting you in Madrid!

In the meantime, let us know what your past experiences have been like at CPhI, and what you are expecting this year. You can either contact us on Twitter (PharmTech.com/Twitter), LinkedIn (PharmTech.com/LinkedIn) or leave a message below.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here